6.3 Topical Therapeutics, Emollients & Skin Barriers

6.3 Topical Therapeutics, Emollients & Skin Barriers

Clinical Pearl: The application of topical pharmacotherapy in foot care nursing requires precise matching of drug pharmacology to tissue pathophysiology. Prescribing or recommending an agent without considering vehicle characteristics, application boundaries, or systemic comorbidities can transform a treatable dermatosis into an open ulceration. From selecting fungicidal versus fungistatic antifungals to enforcing an absolute ban on caustic over-the-counter salicylic acid pads in neuropathic limbs, the Certified Foot Care Nurse acts as an essential safeguard for lower extremity preservation.

---

Topical Antifungal Pharmacotherapy: Allylamines vs. Azoles

Topical antifungal agents form the pharmacological backbone for managing superficial fungal dermatophytoses, including tinea pedis and cutaneous candidiasis. Clinicians must understand the distinct pharmacological classifications, cellular mechanisms, and treatment durations governing these agents.

+-------------------------------------------------------------------------+
|                   TOPICAL ANTIFUNGAL PHARMACOLOGY                       |
+-------------------------------------------------------------------------+
|                                                                         |
|  Squalene  ----------------------->  Lanosterol  ---------------------> |
|     |                                     |                             |
|     | [Squalene Epoxidase]                | [14-alpha-Demethylase]      |
|     | (Blocked by ALLYLAMINES)            | (Blocked by AZOLES)         |
|     v                                     v                             |
|  Accumulation of toxic squalene      Ergosterol Synthesis Halted        |
|  + Cell Membrane Lysis               + Cell Division Arrested           |
|  ==> FUNGICIDAL (Terbinafine)        ==> FUNGISTATIC (Clotrimazole)     |
|                                                                         |
+-------------------------------------------------------------------------+

1. Allylamines (Terbinafine, Naftifine, Butenafine)

• Mechanism of Action: Allylamines act early in the fungal ergosterol biosynthetic pathway by selectively and reversibly inhibiting the fungal enzyme squalene epoxidase. This enzymatic blockade exerts a powerful dual effect:
  1. It arrests ergosterol synthesis, depriving the fungal cell membrane of its essential structural sterol.
  2. It triggers a massive intracellular accumulation of toxic squalene hydrocarbon precursors within the fungal cell. Squalene disrupts fungal lipid membranes, alters permeability, and causes rapid cell membrane rupture and fungal cell lysis.
• Pharmacological Profile: Allylamines are primarily fungicidal against dermatophytes (Trichophyton, Epidermophyton, Microsporum). Because they actively kill fungal hyphae rather than merely arresting growth, allylamines boast significantly higher mycological cure rates and require much shorter therapeutic courses.
• Representative Agent: Terbinafine 1% (Lamisil AT) cream, gel, or spray. Applied once or twice daily for only 1 to 2 weeks for interdigital tinea pedis (and 2 weeks for plantar moccasin tinea pedis).

2. Azoles (Imidazoles & Triazoles: Clotrimazole, Miconazole, Ketoconazole, Econazole)

• Mechanism of Action: Azoles target a downstream step in fungal ergosterol synthesis by selectively inhibiting the cytochrome P450-dependent enzyme lanosterol 14-alpha-demethylase. This enzyme converts lanosterol into ergosterol. Inhibiting this enzyme depletes ergosterol and accumulates methylated 14-alpha-sterols within the fungal cell membrane, altering membrane fluidity, impairing membrane-bound nutrient transport, and stopping fungal cellular replication.
• Pharmacological Profile: Azoles are primarily fungistatic against dermatophytes (though fungicidal against certain Candida species at high concentrations). Because they arrest fungal reproduction without immediately lysing existing mature fungal cells, the host relies on natural epidermal desquamation to shed the inhibited fungi.
• Treatment Implications: Azoles require significantly longer treatment regimens—typically applied twice daily for 2 to 4 continuous weeks. Patient non-adherence is frequent because symptoms subside before the fungal organism is fully shed, leading to high recurrence rates.

3. Clinical Protocols for Tinea Pedis Management

To ensure complete eradication and prevent chronic relapse, the nurse must teach patients three non-negotiable application protocols:

1. Application Beyond the Active Margin: Topical antifungal creams must never be dabbed solely on the visible center of the rash. Clinicians must educate patients to wash and meticulously dry the foot, then apply the medication extending at least 2 to 4 centimeters (approximately 1 inch) beyond all visible erythematous, scaling, or active borders. Fungal hyphae continuously proliferate into clinically normal-appearing perilesional skin; treating only visible lesions guarantees failure.
2. Treatment Duration Past Symptom Resolution: Patients must continue applying the topical agent for 1 to 2 full weeks after all visible redness, scaling, and itching have completely resolved. Premature discontinuation leaves microscopic subclinical hyphae and dormant arthroconidia (spores) embedded in the stratum corneum, causing rapid clinical relapse.
3. Sanitizing Footwear and Environmental Reservoirs: Tinea pedis cannot be cured if the patient's footwear remains contaminated with infectious arthrospores, which survive in shed keratin scales inside shoes for up to 12 to 24 months. The nurse must instruct the patient to:
   • Wash all socks in hot water (>= 140°F / 60°C) or use color-safe bleach to denature fungal proteins.
   • Dust footwear interiors daily with over-the-counter antifungal powders (e.g., miconazole, tolnaftate) or treat with aerosolized antifungal sprays.
   • Utilize ultraviolet (UV) shoe sanitizing inserts designed to destroy microbial DNA.
   • Alternate shoes daily, ensuring each pair dries for a minimum of 24 to 48 hours between wearings.

---

Keratolytic Formulations: Controlled Debridement vs. Caustic Hazards

Keratolytics are chemical agents that break down, soften, and dissolve the stratum corneum. When selected and applied appropriately, they provide controlled, gentle chemical debridement of hyperkeratotic tissue. When misused, they produce catastrophic full-thickness chemical necrosis.

1. High-Concentration Urea (20% to 40%)

• Mechanism: Urea is an endogenous metabolite that at high concentrations acts as a powerful, non-caustic keratolytic. It denatures hydrogen bonds within keratin intermediate filaments, destabilizes protein architecture, and hydrolyzes corneodesmosomes. This dissolves the intercellular cement binding hyperkeratotic plaques together, causing rapid softening and desquamation of thick calluses and calcaneal fissures.
• Safety Profile: Unlike caustic acids, urea possesses an exceptional margin of safety. It does not induce coagulation or liquefaction chemical necrosis of underlying viable dermal tissue. It can be safely utilized on high-risk diabetic feet with intact hyperkeratosis to soften callosities prior to conservative sharp debridement or as ongoing home maintenance.
• Application: Apply once or twice daily to thick calluses, heel fissures, or dystrophic nails. Covering the foot with a clean cotton sock after application enhances epidermal penetration.

2. Ammonium Lactate (12% Formulation)

• Mechanism: An alpha-hydroxy acid formulation consisting of lactic acid neutralized with ammonium hydroxide. It reduces corneocyte adhesion within the lower, newly formed layers of the stratum corneum while stimulating epidermal ceramide biosynthesis and granular layer proliferation.
• Clinical Indications: Indicated for severe xerosis, generalized lower extremity scaling, ichthyosis vulgaris, and follicular keratosis. Apply twice daily to intact, dry lower legs and feet.

3. Salicylic Acid: Safe Low-Dose Use vs. The Deadly 40% OTC Hazard

• Mechanism: Salicylic acid is a lipid-soluble beta-hydroxy acid that solubilizes the intercellular lipid matrix and degrades desmosomes, producing widespread epidermal peeling.
• Safe Low-Dose Formulations (3% to 6%): Formulated in mild creams or petrolatum ointments, low-dose salicylic acid can be used under close clinical supervision to gently soften circumscribed plantar plaques in patients with normal vascularity and intact sensation.

+-------------------------------------------------------------------------+
|     THE DEADLY HAZARD: 40% SALICYLIC ACID OVER-THE-COUNTER PADS         |
+-------------------------------------------------------------------------+
|                                                                         |
|  [Patient with Neuropathy / PAD applies 40% Salicylic Acid Medicated Disc]|
|                                    |
|                                    v
|  Indiscriminate Acid Penetration (Dissolves Keratin & Viable Dermis)    |
|                                    |
|                                    v
|  Patient Lacks Pain Sensation -> Acid Left On for Days / Excessive Depth |
|                                    |
|                                    v
|  Full-Thickness Chemical Burn & Liquefaction Necrosis                   |
|                                    |
|                                    v
|  Secondary Polymicrobial Infection + Severe Ischemic Healing Failure    |
|                                    |
|                                    v
|  Deep Fascial Phlegmon / Calcaneal Osteomyelitis -> AMPUTATION          |
|                                                                         |
+-------------------------------------------------------------------------+

CRITICAL NURSING MANDATE:
Over-the-counter 40% salicylic acid corn/callus pads are ABSOLUTELY CONTRAINDICATED in patients with diabetes, peripheral neuropathy, or peripheral arterial disease!

• The Clinical Hazard: Ubiquitous drugstore "corn removal kits" contain adhesive discs impregnated with 40% salicylic acid. Salicylic acid is a caustic organic acid that cannot discriminate between non-viable hyperkeratotic callus and viable vascular dermis.
• In a patient with peripheral sensory neuropathy, the normal warning sensations of burning, stinging, and chemical injury are absent. The patient leaves the caustic pad in place for days. The concentrated acid dissolves the stratum corneum, burns directly through the dermal-epidermal basement membrane, and liquefies viable subcutaneous tissue.
• In patients with compromised peripheral arterial perfusion, the resulting deep chemical ulcer cannot mount an inflammatory repair response. The wound rapidly develops secondary polymicrobial infection, tracks along plantar tendon sheaths into deep fascial spaces, causes acute osteomyelitis, and frequently results in transmetatarsal or below-knee amputation. Certified Foot Care Nurses must actively inspect for these pads and educate patients, families, and facility staff regarding their absolute danger.

---

Barrier Films and Cutaneous Protectants

Periwound skin management is a cornerstone of lower extremity wound and moisture care. In wounds with heavy exudate (such as venous leg ulcers or neurotrophic ulcers), exudate containing destructive matrix metalloproteinases (MMPs) and inflammatory cytokines macerates, excoriates, and digests surrounding periwound skin. Topical barrier protectants shield vulnerable tissue from maceration and adhesive trauma.

1. Liquid Acrylate Terpolymer Barrier Films ("No-Sting" Skin Prep)

• Composition & Action: Formulated as an alcohol-free liquid polymer composed of an acrylate terpolymer dissolved in a non-cytotoxic polyphenylmethylsiloxane solvent. When wiped or sprayed onto skin, the rapid-evaporating solvent dissipates, leaving an ultra-thin, transparent, flexible, breathable polymeric film.
• "No-Sting" Formula: Traditional skin preps contained alcohol, causing excruciating stinging and pain when applied to excoriated, denuded, or fissured skin. Alcohol-free liquid acrylates do not sting, making them ideal for broken or inflamed tissue.
• Clinical Indications:
  • Periwound Protection: Applied in a halo around draining ulcers to protect periwound tissue from exudate maceration and enzymatic digestion.
  • Adhesive Protection: Protects fragile skin from medical adhesive-related skin injuries (MARSI) caused by repeated tape or adhesive dressing removal. Adhesive dressings adhere to the polymer film rather than the epidermis, preserving stratum corneum integrity during dressing changes.
  • Moisture-Associated Skin Damage (MASD): Shields interdigital spaces and skin folds from urinary, fecal, or perspiration maceration.
  • Longevity: Provides continuous barrier protection for up to 72 hours; does not require removal between dressing changes as it wears off naturally with shedding corneocytes.

2. Zinc Oxide Pastes and Petrolatum-Based Ointments

• Zinc Oxide Pastes (e.g., 20%–40% Zinc Oxide): Formulated as thick, white, opaque hydrophobic pastes. Zinc oxide provides an impenetrable physical barrier against severe corrosive wound exudate, enzymes, and moisture. It exerts mild astringent, soothing, and antibacterial properties.
  • Clinical Caution: Thick zinc oxide paste is difficult to wash off. Nurses must never scrub zinc oxide off fragile periwound skin, as mechanical friction causes immediate epidermal tearing. Gently cleanse the superficial soiled layer with mineral oil or warm water, leaving the base layer intact.
• Dimethicone Formulations (1%–5%): Silicone-based emulsions that form a breathable, transparent, non-greasy water-repellent barrier. Highly effective for protecting heels and ankles from friction shearing and mild perspiration maceration without interfering with tape adhesion.

---

Plantar Hyperhidrosis: Pathophysiology and Multi-Modal Management

Plantar hyperhidrosis is the excessive, unprovoked secretion of eccrine sweat glands on the soles of the feet, substantially exceeding the volume required for physiological thermoregulation. The human sole contains the highest density of eccrine sweat glands on the body (>250 to 600 glands per square centimeter, totaling over 250,000 glands on both feet).

Clinical Significance and Complications

Plantar hyperhidrosis is not merely a cosmetic nuisance; it carries severe clinical consequences:

1. Continuous Cutaneous Maceration: Stratum corneum becomes permanently hyperhydrated, soft, and friable, drastically lowering skin tensile strength.
2. Friction Blister Formation: Excessive moisture alters the skin friction coefficient. During ambulation, damp stratum corneum sticks to inner socks while deep dermis moves with bone, creating severe intraepidermal shearing that shears open large, painful friction blisters.
3. Microbial Proliferation & Bromhidrosis: Hyperhidrosis elevates cutaneous pH into the alkaline range, encouraging the rapid growth of dermatophytes (Tinea pedis) and bacteria such as Brevibacterium and Corynebacterium. These bacteria metabolize sweat and keratin into volatile fatty acids and sulfur compounds (methanethiol), producing intense, foul foot odor (bromhidrosis).
4. Pitted Keratolysis: Bacterial overgrowth (Kytococcus sedentarius, Dermatophilus congolensis) produces proteinase enzymes that digest small, discrete, crater-like pits (1–5 mm) in the weight-bearing plantar stratum corneum, accompanied by painful burning and severe odor.

Multi-Modal Clinical Interventions

+-------------------------------------------------------------------------+
|             MULTI-MODAL PLANTAR HYPERHIDROSIS PROTOCOL                  |
+-------------------------------------------------------------------------+
|                                                                         |
|  1. PHARMACOLOGICAL (Aluminum Chloride Hexahydrate 15%–20%)             |
|     - Apply at bedtime to bone-dry soles; wash off in morning           |
|     - Metal ions precipitate with mucopolysaccharides in sweat ducts    |
|     - Forms physical obstructant keratin plugs halting perspiration     |
|                                                                         |
|  2. ABSORBENT POWDERS (Non-Medicated Pure Cornstarch)                   |
|     - Dust lightly into socks and shoe footbeds                         |
|     - Absorbs active perspiration; avoid clumping and talc              |
|                                                                         |
|  3. TEXTILE MANAGEMENT (Moisture-Wicking Synthetic / Merino Wool)       |
|     - CoolMax, polypropylene, acrylic, or merino wool fibers            |
|     - Wicks sweat away to outer sock layer for evaporation              |
|     - STRICTLY AVOID 100% COTTON (acts like a wet sponge)               |
|                                                                         |
|  4. FOOTWEAR ROTATION & AERATION                                        |
|     - Rotate shoes daily; enforce 24- to 48-hour drying interval        |
|     - Wear breathable leather or mesh; remove moisture-soaked insoles   |
|                                                                         |
+-------------------------------------------------------------------------+

1. Topical Aluminum Chloride Hexahydrate (15% to 20% Formulation):
   • Mechanism: The gold-standard first-line medical intervention for plantar hyperhidrosis. Aluminum chloride hexahydrate is applied in an anhydrous ethyl alcohol vehicle. When applied to the skin, aluminum ions diffuse down into the terminal lumen of eccrine sweat ducts. The aluminum reacts with intraductal water and mucopolysaccharides, forming an insoluble, gelatinous aluminum-keratin complex precipitate that forms a physical plug obstructing the eccrine duct, halting sweat release.
   • Application Protocol: Must be applied at bedtime to completely dry plantar skin. Applying to damp skin causes hydrolysis into hydrochloric acid, causing severe stinging, erythema, and chemical irritation. The medication is washed off the following morning with soap and water. Applied nightly for 1 to 2 weeks until perspiration is controlled, then maintained once every 1 to 2 weeks thereafter.
2. Absorbent Foot Powders:
   • Non-medicated, pure cornstarch-based foot powders may be applied lightly to the plantar skin, web spaces, and footwear insoles. Cornstarch absorbs excess surface moisture without chemical irritation.
   • Caution: Avoid over-application that causes powder to form abrasive, pasty clumps in the toe clefts. Avoid talcum-based powders due to respiratory inhalation hazards.
3. Footwear Textile Selection: The Cotton Sock Hazard:
   • Patients with hyperhidrosis must be strictly instructed to avoid 100% cotton socks. Cotton is a hydrophilic cellulose fiber that absorbs moisture rapidly and holds it trapped against the skin like a wet sponge, promoting continuous maceration and high friction blister shearing.
   • Recommend moisture-wicking synthetic fiber blends (polypropylene, acrylic, CoolMax, polyester) or high-grade merino wool. These technical fibers possess hydrophobic cores and capillary channels that actively pull moisture away from the skin surface and transport it to the outer surface of the sock, where it evaporates freely.
4. Footwear Rotation and Drying:
   • Patients must never wear the same pair of shoes on consecutive days. Enforce a strict 24- to 48-hour shoe rotation to allow footwear insoles and linings to dissipate accumulated moisture completely.
   • Recommend shoes constructed with breathable leather uppers or athletic mesh, and advise removing removable orthotic insoles nightly to accelerate drying.